Introducing our new hematologic oncologist, Dr. Wayne Ormsby. For Dr. Ormsby, hematology provides an opportunity to establish close relationships with his patients and to participate in a field with continuous advances in treatment options. Read more.
After Willamette Valley Cancer Institute upgraded more than 125 PCs and laptops at the Eugene location this April, David Eccles, our IT coordinator, explored whether the equipment could be donated to benefit the community. And that's exactly what he found with NextStep Recycling in West Eugene. Read more.
A diagnosis of cancer immediately presents you with a raft of decisions to make. You first need to know your specific diagnosis, the kind and stage of cancer, and then there are your treatment options to consider. At WVCI, we strive for patient involvement to the utmost, for you to understand the scope of standard treatment and the parameters of clinical trials. We're here to help you make the best treatment decision for you. Read more.
A board-certified hematologist, Dr. Christopher A. Yasenchak works as a co-investigator for numerous clinical trials, investigating novel treatments for hematologic malignancies. He has a passion for research and for providing access to state-of-the-art clinical trials in the communities where his patients live. Read more.
Almost universally, diagnosed cancer patients find themselves asking, "Why me?" Even though medical research has yet to find a precise scientific answer, we do know enough about lymphocyte biology to make some educated inferences about the cause of lymphoma and chronic lymphocytic leukemia (CLL). Read more.